Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Isakson, PC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yaksh, TL; Dirig, DM; Conway, CM; Svensson, C; Luo, ZD; Isakson, PC
      The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugsand release of spinal prostaglandin E-2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1

      JOURNAL OF NEUROSCIENCE
    2. Walker, MC; Kurumbail, RG; Kiefer, JR; Moreland, KT; Koboldt, CM; Isakson, PC; Seibert, K; Gierse, JK
      A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors

      BIOCHEMICAL JOURNAL
    3. Leese, PT; Hubbard, RC; Karim, A; Isakson, PC; Yu, SS; Geis, GS
      Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial

      JOURNAL OF CLINICAL PHARMACOLOGY
    4. Khanna, IK; Yu, Y; Huff, RM; Weier, RM; Xu, XD; Koszyk, FJ; Collins, PW; Cogburn, JN; Isakson, PC; Koboldt, CM; Masferrer, JL; Perkins, WE; Seibert, K; Veenhuizen, AW; Yuan, JH; Yang, DC; Zhang, YY
      Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents

      JOURNAL OF MEDICINAL CHEMISTRY
    5. Whelton, A; Schulman, G; Wallemark, C; Drower, EJ; Isakson, PC; Verburg, KM; Geis, GS
      Effects of celecoxib and naproxen on renal function in the elderly

      ARCHIVES OF INTERNAL MEDICINE
    6. Sheng, HM; Shao, JY; O'Mahony, CA; Lamps, L; Albo, D; Isakson, PC; Berger, DH; DuBois, RN; Beauchamp, RD
      Transformation of intestinal epithelial cells by chronic TGF-beta 1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2

      ONCOGENE
    7. Gierse, JK; Koboldt, CM; Walker, MC; Seibert, K; Isakson, PC
      Kinetic basis for selective inhibition of cyclo-oxygenases

      BIOCHEMICAL JOURNAL
    8. Emery, P; Zeidler, H; Kvien, TK; Guslandi, M; Naudin, R; Stead, H; Verburg, KM; Isakson, PC; Hubbard, RC; Geis, GS
      Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison

      LANCET
    9. Simon, LS; Weaver, AL; Graham, DY; Kivitz, AJ; Lipsky, PE; Hubbard, RC; Isakson, PC; Verburg, KM; Yu, SS; Zhao, WW; Geis, GS
      Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    10. Bensen, WG; Fiechtner, JJ; McMillen, JI; Zhao, WW; Yu, SS; Woods, EM; Hubbard, RC; Isakson, PC; Verburg, KM; Geis, GS
      Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial

      MAYO CLINIC PROCEEDINGS
    11. MARGALIT A; HAUSER SD; ZWEIFEL BS; ANDERSON MA; ISAKSON PC
      REGULATION OF PROSTAGLANDIN BIOSYNTHESIS IN-VIVO BY GLUTATHIONE

      American journal of physiology. Regulatory, integrative and comparative physiology
    12. SMITH CJ; ZHANG Y; KOBOLDT CM; MUHAMMAD J; ZWEIFEL BS; SHAFFER A; TALLEY JJ; MASFERRER JL; SEIBERT K; ISAKSON PC
      PHARMACOLOGICAL ANALYSIS OF CYCLOOXYGENASE-1 IN INFLAMMATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    13. NAKAYAMA M; UCHIMURA K; ZHU RL; NAGAYAMA T; ROSE ME; STETLER RA; ISAKSON PC; CHEN J; GRAHAM SH
      CYCLOOXYGENASE-2 INHIBITION PREVENTS DELAYED DEATH OF CA1 HIPPOCAMPAL-NEURONS FOLLOWING GLOBAL-ISCHEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America
    14. DIRIG DM; ISAKSON PC; YAKSH TL
      EFFECT OF COX-1 AND COX-2 INHIBITION ON INDUCTION AND MAINTENANCE OF CARRAGEENAN-EVOKED THERMAL HYPERALGESIA IN RATS

      The Journal of pharmacology and experimental therapeutics
    15. SIMON LS; LANZA FL; LIPSKY PE; HUBBARD RC; TALWALKER S; SCHWARTZ BD; ISAKSON PC; GEIS GS
      PRELIMINARY-STUDY OF THE SAFETY AND EFFICACY OF SC-58635, A NOVEL CYCLOOXYGENASE-2 INHIBITOR - EFFICACY AND SAFETY IN 2 PLACEBO-CONTROLLED TRIALS IN OSTEOARTHRITIS AND RHEUMATOID-ARTHRITIS, AND STUDIES OF GASTROINTESTINAL AND PLATELET EFFECTS

      Arthritis and rheumatism
    16. PENNING TD; KRAMER SW; LEE LF; COLLINS PW; KOBOLDT CM; SEIBERT K; VEENHUIZEN AW; ZHANG YY; ISAKSON PC
      3,4-DIARYLPYRAZOLES - POTENT AND SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2

      Bioorganic & medicinal chemistry letters
    17. KAUFMANN WE; WORLEY PF; TAYLOR CV; BREMER M; ISAKSON PC
      CYCLOOXYGENASE-2 EXPRESSION DURING RAT NEOCORTICAL DEVELOPMENT AND INRETT-SYNDROME

      Brain & development
    18. MARGALIT A; DUFFIN KL; SHAFFER AF; GREGORY SA; ISAKSON PC
      ALTERED ARACHIDONIC-ACID METABOLISM IN URATE CRYSTAL-INDUCED INFLAMMATION

      Inflammation
    19. NEEDLEMAN P; ISAKSON PC
      THE DISCOVERY AND FUNCTION OF COX-2

      Journal of rheumatology
    20. LIPSKY PE; ISAKSON PC
      OUTCOME OF SPECIFIC COX-2 INHIBITION IN RHEUMATOID-ARTHRITIS

      Journal of rheumatology
    21. KAUFMANN WE; ANDREASSON KL; ISAKSON PC; WORLEY PF
      CYCLOOXYGENASES AND THE CENTRAL-NERVOUS-SYSTEM

      Prostaglandins
    22. KURUMBAIL RG; STEVENS AM; GIERSE JK; MCDONALD JJ; STEGEMAN RA; PAK JY; GILDEHAUS D; MIYASHIRO JM; PENNING TD; SEIBERT K; ISAKSON PC; STALLINGS WC
      STRUCTURAL BASIS FOR SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 BY ANTIINFLAMMATORY AGENTS (VOL 384, PG 644, 1996)

      Nature
    23. ZHANG Y; SHAFFER A; PORTANOVA J; SEIBERT K; ISAKSON PC
      INHIBITION OF CYCLOOXYGENASE-2 RAPIDLY REVERSES INFLAMMATORY HYPERALGESIA AND PROSTAGLANDIN E-2 PRODUCTION

      The Journal of pharmacology and experimental therapeutics
    24. PENNING TD; TALLEY JJ; BERTENSHAW SR; CARTER JS; COLLINS PW; DOCTER S; GRANETO MJ; LEE LF; MALECHA JW; MIYASHIRO JM; ROGERS RS; ROGIER DJ; YU SS; ANDERSON GD; BURTON EG; COGBURN JN; GREGORY SA; KOBOLDT CM; PERKINS WE; SEIBERT K; VEENHUIZEN AW; ZHANG YY; ISAKSON PC
      SYNTHESIS AND BIOLOGICAL EVALUATION OF THE 1,5-DIARYLPYRAZOLE CLASS OF CYCLOOXYGENASE-2 INHIBITORS - IDENTIFICATION OF RIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE (SC-58635, CELECOXIB)

      Journal of medicinal chemistry
    25. KHANNA IK; WEIER RM; YU Y; COLLINS PW; MIYASHIRO JM; KOBOLDT CM; VEENHUIZEN AW; CURRIE JL; SEIBERT K; ISAKSON PC
      1,2-DIARYLPYRROLES AS POTENT AND SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2

      Journal of medicinal chemistry
    26. KHANNA IK; WEIER RM; YU Y; XU XD; KOSZYK FJ; COLLINS PW; KOBOLDT CM; VEENHUIZEN AW; PERKINS WE; CASLER JJ; MASFERRER JL; ZHANG YY; GREGORY SA; SEIBERT K; ISAKSON PC
      1,2-DIARYLIMIDAZOLES AS POTENT, CYCLOOXYGENASE-2 SELECTIVE, AND ORALLY-ACTIVE ANTIINFLAMMATORY AGENTS

      Journal of medicinal chemistry
    27. SHENG GG; SHAO JY; SHENG HM; HOOTON EB; ISAKSON PC; MORROW JD; COFFEY RJ; DUBOIS RN; BEAUCHAMP RD
      A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR SUPPRESSES THE GROWTH OF H-RAS-TRANSFORMED RAT INTESTINAL EPITHELIAL-CELLS

      Gastroenterology
    28. SHENG H; SHAO J; HOOTON EB; LAMPS L; ISAKSON PC; MORROW JD; DUBOIS RN; BEAUCHAMP RD
      CHRONIC TGF-BETA TREATMENT CAUSES MALIGNANT TRANSFORMATION OF RAT INTESTINAL EPITHELIAL-CELLS (RIE-1) ASSOCIATED WITH OVEREXPRESSION OF CYCLOOXYGENASE-2

      Gastroenterology
    29. SHENG GG; SHAO J; SHENG H; HOOTON EB; ISAKSON PC; MORROW JD; COFFEY RJ; DUBOIS RN; BEAUCHAMP RD
      A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR (SC-58125) SUPPRESSES THE GROWTH OF H-RAS-TRANSFORMED RAT INTESTINAL EPITHELIAL-CELLS

      Gastroenterology
    30. DIRIG DM; KONIN GP; ISAKSON PC; YAKSH TL
      EFFECT OF SPINAL CYCLOOXYGENASE INHIBITORS IN RAT USING THE FORMALIN TEST AND IN-VITRO PROSTAGLANDIN E-2 RELEASE

      European journal of pharmacology
    31. MENGLEGAW L; HUBBARD RC; KARIM A; YU SS; TALWALKER S; ISAKSON PC; GEIS GS; SCHWARTZ BD
      A STUDY OF THE PLATELET EFFECTS OF SC-58635, A NOVEL COX-2-SELECTIVE INHIBITOR

      Arthritis and rheumatism
    32. DIRIG DM; ISAKSON PC; YAKSH TL
      SPINAL AND SYSTEMIC CYCLOOXYGENASE (COX) INHIBITORS SUPPRESS PAW CARRAGEENAN-EVOKED THERMAL HYPERALGESIA IN RATS

      Anesthesiology
    33. HUBBARD RC; MEHLISCH DR; JASPER DR; NUGENT MJ; YU S; ISAKSON PC
      SC-58635, A HIGHLY SELECTIVE INHIBITOR OF COX-2, IS AN EFFECTIVE ANALGESIC IN AN ACUTE POSTSURGICAL PAIN MODEL

      Journal of investigative medicine
    34. MASFERRER JL; ISAKSON PC; SEIBERT K
      CYCLOOXYGENASE-2 INHIBITORS - A NEW CLASS OF ANTIINFLAMMATORY AGENTS THAT SPARE THE GASTROINTESTINAL-TRACT

      Gastroenterology clinics of North America
    35. KURUMBAIL RG; STEVENS AM; GIERSE JK; MCDONALD JJ; STEGEMAN RA; PAK JY; GILDEHAUS D; MIYASHIRO JM; PENNING TD; SEIBERT K; ISAKSON PC; STALLINGS WC
      STRUCTURAL BASIS FOR SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 BY ANTIINFLAMMATORY AGENTS

      Nature
    36. LI JJ; NORTON MB; REINHARD EJ; ANDERSON GD; GREGORY SA; ISAKSON PC; KOBOLDT CM; MASFERRER JL; PERKINS WE; SEIBERT K; ZHANG Y; ZWEIFEL BS; REITZ DB
      NOVEL TERPHENYLS AS SELECTIVE CYCLOOXYGENASE-2 INHIBITORS AND ORALLY-ACTIVE ANTIINFLAMMATORY AGENTS

      Journal of medicinal chemistry
    37. HUANG HC; LI JJ; GARLAND DJ; CHAMBERLAIN TS; REINHARD EJ; MANNING RE; SEIBERT K; KOBOLDT CM; GREGORY SA; ANDERSON GD; VEENHUIZEN AW; ZHANG Y; PERKINS WE; BURTON EG; COGBURN JN; ISAKSON PC; REITZ DB
      DIARYLSPIRO[2.4]HEPTENES AS ORALLY-ACTIVE, HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITORS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    38. WEBER JD; ISAKSON PC; PURKERSON JM
      IL-5 RECEPTOR EXPRESSION AND IG SECRETION FROM MURINE B-LYMPHOCYTES REQUIRES COORDINATED SIGNALING BY MEMBRANE IG, IL-4, AND IL-5

      The Journal of immunology
    39. PORTANOVA JP; ZHANG Y; ANDERSON GD; HAUSER SD; MASFERRER JL; SEIBERT K; GREGORY SA; ISAKSON PC
      SELECTIVE NEUTRALIZATION OF PROSTAGLANDIN E(2) BLOCKS INFLAMMATION, HYPERALGESIA, AND INTERLEUKIN-6 PRODUCTION IN-VIVO

      The Journal of experimental medicine
    40. MARGALIT A; DUFFIN KL; ISAKSON PC
      RAPID QUANTITATION OF A LARGE SCOPE OF EICOSANOIDS IN 2 MODELS OF INFLAMMATION - DEVELOPMENT OF AN ELECTROSPRAY AND TANDEM MASS-SPECTROMETRY METHOD AND APPLICATION TO BIOLOGICAL STUDIES

      Analytical biochemistry
    41. REITZ DB; HUANG HC; LI JJ; GARLAND DJ; MANNING RE; ANDERSON GD; GREGORY SA; KOBOLDT CM; PERKINS WE; SEIBERT K; ISAKSON PC
      SELECTIVE CYCLOOXYGENASE INHIBITORS - NOVEL 4-SPIRO 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY-ACTIVE COX-2 INHIBITORS

      Bioorganic & medicinal chemistry letters
    42. HUANG HC; CHAMBERLAIN TS; SEIBERT K; KOBOLDT CM; ISAKSON PC; REITZ DB
      DIARYL INDENES AND BENZOFURANS - NOVEL CLASSES OF POTENT AND SELECTIVE CYCLOOXYGENASE-2 INHIBITORS

      Bioorganic & medicinal chemistry letters
    43. ZWEIFEL BS; COLBURN SM; ORNBERG RL; ISAKSON PC; SEIBERT K; MASFERRER JL
      THE ROLE OF CYCLOOXYGENASE-2 IN INFLAMMATION

      The FASEB journal
    44. GIERSE JK; HAUSER SD; CREELY DP; KOBOLDT C; RANGWALA SH; ISAKSON PC; SEIBERT K
      EXPRESSION AND SELECTIVE-INHIBITION OF THE CONSTITUTIVE AND INDUCIBLEFORMS OF HUMAN CYCLOOXYGENASE

      Biochemical journal
    45. SMITH WG; SHAFFER AF; CURRIE JL; THOMPSON JM; KIM S; RAO T; ISAKSON PC
      CHARACTERIZATION OF 5-LIPOXYGENASE INHIBITORS IN BIOCHEMICAL AND FUNCTIONAL IN-VIVO ASSAYS

      The Journal of pharmacology and experimental therapeutics
    46. LI JJ; ANDERSON GD; BURTON EG; COGBURN JN; COLLINS JT; GARLAND DJ; GREGORY SA; HUANG HC; ISAKSON PC; KOBOLDT CM; LOGUSCH EW; NORTON MB; PERKINS WE; REINHARD EJ; SEIBERT K; VEENHUIZEN AW; ZHANG Y; REITZ DB
      1,2-DIARYLCYCLOPENTENES AS SELECTIVE CYCLOOXYGENASE-2 INHIBITORS AND ORALLY-ACTIVE ANTIINFLAMMATORY AGENTS

      Journal of medicinal chemistry
    47. MNICH SJ; VEENHUIZEN AW; MONAHAN JB; SHEEHAN KCF; LYNCH KR; ISAKSON PC; PORTANOVA JP
      CHARACTERIZATION OF A MONOCLONAL-ANTIBODY THAT NEUTRALIZES THE ACTIVITY OF PROSTAGLANDIN E(2)

      The Journal of immunology
    48. RAO TS; YU SS; DJURIC SW; ISAKSON PC
      PHORBOL ESTER-INDUCED DERMAL INFLAMMATION IN MICE - EVALUATION OF INHIBITORS OF 5-LIPOXYGENASE AND ANTAGONISTS OF LEUKOTRIENE B-4 RECEPTOR

      Journal of lipid mediators and cell signalling
    49. GIERSE JK; HAUSER SD; CREELY DP; RANGWALA SH; THIELE BR; ISAKSON PC; SEIBERT K
      EXPRESSION AND SELECTIVE-INHIBITION OF THE CONSTITUTIVE AND INDUCIBLEFORMS OF HUMAN CYCLOOXYGENASE

      The FASEB journal
    50. RAO TS; SHAFFER AF; CURRIE JL; ISAKSON PC
      ROLE OF MAST-CELLS IN CALCIUM IONOPHORE (A23187)-INDUCED PERITONEAL INFLAMMATION IN MICE

      Inflammation
    51. MASFERRER JL; ZWEIFEL BS; MANNING PT; HAUSER SD; LEAHY KM; SMITH WG; ISAKSON PC; SEIBERT K
      SELECTIVE-INHIBITION OF INDUCIBLE CYCLOOXYGENASE-2 IN-VIVO IS ANTIINFLAMMATORY AND NONULCEROGENIC

      Proceedings of the National Academy of Sciences of the United Statesof America
    52. WELSCH DJ; CREELY DP; HAUSER SD; MATHIS KJ; KRIVI GG; ISAKSON PC
      MOLECULAR-CLONING END EXPRESSION OF HUMAN LEUKOTRIENE-C-4 SYNTHASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. RAO TS; CURRIE JL; SHAFFER AF; ISAKSON PC
      IN-VIVO CHARACTERIZATION OF ZYMOSAN-INDUCED MOUSE PERITONEAL INFLAMMATION

      The Journal of pharmacology and experimental therapeutics
    54. REITZ DB; LI JJ; NORTON MB; REINHARD EJ; COLLINS JT; ANDERSON GD; GREGORY SA; KOBOLDT CM; PERKINS WE; SEIBERT K; ISAKSON PC
      SELECTIVE CYCLOOXYGENASE INHIBITORS - NOVEL 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY-ACTIVE COX-2 INHIBITORS

      Journal of medicinal chemistry
    55. PURKERSON JM; ISAKSON PC
      INDEPENDENT REGULATION OF DNA RECOMBINATION AND IMMUNOGLOBULIN (IG) SECRETION DURING ISOTYPE SWITCHING TO IGG1 AND IGE

      The Journal of experimental medicine
    56. RAO TS; CURRIE JL; SHAFFER AF; ISAKSON PC
      CALCIUM IONOPHORE (A-23187) INDUCED PERITONEAL EICOSANOID BIOSYNTHESIS - A RAPID METHOD TO EVALUATE INHIBITORS OF ARACHIDONIC-ACID METABOLISM IN-VIVO

      Mediators of inflammation
    57. RAO TS; CURRIE JL; SHAFFER AF; ISAKSON PC
      COMPARATIVE-EVALUATION OF ARACHIDONIC-ACID (AA)-INDUCED AND TETRADECANOYLPHORBOL ACETATE (TPA)-INDUCED DERMAL INFLAMMATION

      Inflammation
    58. RAO TS; CURRIE JL; SHAFFER AF; ISAKSON PC
      EVALUATION OF 5-LIPOXYGENASE INHIBITORS, ZILEUTON, A-78773 AND ICI-D-2138 IN AN IONOPHORE (A-23187)-INDUCED PLEURAL INFLAMMATION MODEL IN THE RAT

      Life sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 16:43:12